The Enterprise Value as of December 2025 (TTM) for Ayala Pharmaceuticals, Inc. (ADXS) is 7.85M

According to Ayala Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.85M. This represents a change of 999.64% compared to the average of 713.57K of the last 4 quarters.

Ayala Pharmaceuticals, Inc. (ADXS) Historical Enterprise Value (quarterly & annually)

How has ADXS Enterprise Value performed in the past?

The mean historical Enterprise Value of Ayala Pharmaceuticals, Inc. over the last ten years is 6.64B. The current 7.85M Enterprise Value has changed -88.18% with respect to the historical average. Over the past ten years (40 quarters), ADXS's Enterprise Value was at its highest in in the July 2015 quarter at 41.58B. The Enterprise Value was at its lowest in in the October 2022 quarter at -21818331.14.

Ayala Pharmaceuticals, Inc. (ADXS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Ayala Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ayala Pharmaceuticals, Inc. (ADXS) Average Enterprise Value

How has ADXS Enterprise Value performed in the past?

The current Enterprise Value of Ayala Pharmaceuticals, Inc. (ADXS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Ayala Pharmaceuticals, Inc. (ADXS) Enterprise Value vs. Peers

How is ADXS’s Enterprise Value compared to its peers?

Ayala Pharmaceuticals, Inc.’s Enterprise Value is greater than Health Sciences Group, Inc. (505.72K), less than Appili Therapeutics Inc. (14.26M), greater than Algernon Pharmaceuticals Inc. (2.65M), greater than Restart Life Sciences Corp. (3.44M), greater than ReNeuron Group plc (-5684904.70), greater than America Great Health (4.75M), greater than VG Life Sciences Inc. (2.11M), greater than Universal Ibogaine Inc. (3.95M), greater than Regen BioPharma, Inc. (1.32M), greater than Agentix Corp. (1.74M),

Build a custom stock screener for Ayala Pharmaceuticals, Inc. (ADXS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ayala Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ayala Pharmaceuticals, Inc. (ADXS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ayala Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.